High-Throughput Phenotypic Assay for Compounds That Influence Mitochondrial Health Using iPSC-Derived Human Neurons.
High-Throughput Phenotypic Assay for Compounds That Influence Mitochondrial Health Using iPSC-Derived Human Neurons.
复制标题
DOI:
10.1177/24725552211000671
复制
发表时间:
2021-07
期刊:
影响因子:
--
通讯作者:
Davis RL
中科院分区:
文献类型:
--
作者:
MacMullen C;Davis RL
There is a critical need to develop high throughput assays to identify compounds that offer therapy for individuals suffering from neurodegenerative diseases. Most brain disorders, including neurodegenerative diseases, share the common neuropathology of mitochondria dysfunction, which can lead to apoptosis of neurons, over-production of reactive oxygen species (ROS), and other cellular neuropathologies characteristic of these diseases. Human iPSCs with a stable genomic insertion of the neurogenin-2 transcription factor under the control of the TetOn promoter can be differentiated into excitatory human neurons (i3Neurons) within 3 days of exposure to doxycycline. These neurons have been used to develop and validate a live cell assay for parameters of mitochondrial dynamics and function using two compounds known to promote mitochondrial elongation in mouse neurons, 4-hydroxychalcone and 2,4-dihyrdroxychalcone. The assay involves plating the neurons in 384 well microtiter plates, treating them with known or unknown substances, and then capturing morphological information for the neuronal mitochondria using a lentivirus vector to express a mitochondrial-targeted fluorescence reporter. The i3Neuron cultures exposed to these two compounds for 24hr exhibit significantly decreased circularity and significantly increased length compared to controls, two morphological parameters correlated with increased mitochondrial health. The assay is rapid, with results obtained after a one week-long i3Neuron culture or one month if neurons are co-cultured with astrocytes. This live cell, mitochondrial phenotypic assay can be used for high-throughput screening or as an orthogonal assay for compounds obtained via other high throughput screening campaigns.
登录
查看更多内容
DOI:
10.1042/bj20081386
发表时间:
2009-01-01
期刊:
The Biochemical journal
影响因子:
--
作者:
Murphy MP
通讯作者:
Murphy MP
影响因子:
13.6
作者:
Varkuti, Boglarka H.;Kepiro, Miklos;Davis, Ronald L.
通讯作者:
Davis, Ronald L.
DOI:
10.1186/1747-5341-4-2
发表时间:
2009-01-15
期刊:
Philosophy, ethics, and humanities in medicine : PEHM
影响因子:
--
作者:
Shanks N;Greek R;Greek J
通讯作者:
Greek J
影响因子:
5.1
作者:
Hoffmann, D.;Schott, J. W.;Schambach, A.
通讯作者:
Schambach, A.
DOI:
10.1124/jpet.112.192138
发表时间:
2012-09-01
影响因子:
3.5
作者:
Johri, Ashu;Beal, M. Flint
通讯作者:
Beal, M. Flint